Statistics for Sarepta Therapeutics (id:7218 SRPT)

Valuation metrics

Market cap

10.00B

Enterprise value

10.20B

Trailing P/E (ttm)

67.97

Forward P/E

9.14

PEG ratio

9.14

Price/Sales (ttm)

6.10

Price/Book (mrq)

8.19

Enterprise Value/Revenue

6.22

Enterprise Value/EBITDA

85.26

Overview

Shares outstanding

95.52M

Float

91.15M

Shares short

5.60M

% Held by insiders

0.04%

% Held by institutions

0.92%

Average volume (10 days)

1.35M

Average volume (90 days)

Price summary

52-Week low

78.67

52-Week high

173.25

52-Week change

27.73%

Beta

0.80

50-Day moving average

123.72

200-Day moving average

130.42

Dividends and splits

Forward annual dividend rate

Forward annual dividend yield

Trailing annual dividend rate

0.00%

Trailing annual dividend yield

0.00

5-Year annual dividend yield

Payout ratio

0.00

Dividend date

Ex-dividend date

Last split factor

2:1

Last split date

July 12th, 2012

Financials

Fiscal year

Fiscal year ends

December 31th, 2023

Most recent quarter (mrq)

September 30th, 2024

Profitability

Profit margin

7.43%

Operating margin

4.75%

Operational effectiveness

Return on assets

1.51%

Return on equity

12.27%

Income statement

Revenue (ttm)

16.92

Revenue per share (ttm)

16.92

Quarterly revenue growth (yoy)

Gross profit (ttm)

1.09B

EBITDA

198.26M

Net income to common (ttm)

121.84M

Diluted EPS (ttm)

1.54

Quarterly earnings growth (yoy)

Balance sheet

Total cash (mrq)

1.20B

Total cash per share (mrq)

12.55

Total debt (mrq)

1.41B

Total Debt/Equity (mrq)

115.87

Current ratio (mrq)

383.90%

Book value per share (mrq)

12.79

Cash flow

Cash flow statement

-352,489,984.00

Levered free cash flow (LFCF)

-482,010,112.00